Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Telehealth & Telemedicine
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
TMR Fibre/laser
Showing all 4 results
Cardiac Surgery Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more
The full report suite on the global market for cardiac surgery device includes the tissue heart valve, mechanical heart valve, annuloplasty repair device, transcatheter mitral valve repair, transcatheter heart valve replacement, cerebral embolic protection device, balloon valvuloplasty, on-pump coronary artery bypass (ONCAB) device, off-pump coronary artery bypass (OPCAB) device, autotransfusion device, endoscopic vessel harvesting device, anastomosis assist device, ventricular assist device, intra-aortic balloon device, artificial heart replacement device, patent foramen ovale closure device, patent ductus arteriosus closure device, atrial and ventricular septal defect closure device, left atrial appendage closure device, preshaped guidewire, transmyocardial revascularization device and extracorporeal membrane oxygenation (ECMO) markets.
more...Cardiac Surgery Market Size, Share, and Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 22 more
Overall, the U.S. cardiac surgery market was valued at $8.4 billion in 2022. This is expected to increase over the forecast period at a CAGR of 6.1% to reach $12.7 billion. Currently, the U.S. cardiac surgery market is dominated by Edwards Lifesciences, Abbott, and Medtronic. Throughout this medical market research, we analyzed over 30 cardiac […]
more...Cardiac Surgery Procedure Volume Analysis | Global | 2021-2027 | MedPro | Segmented by: Material, Indication, Type, and More
Globally, over 6 million cardiac surgery procedures were performed in 2020. The majority of these procedures were autotransfusion procedures followed by surgical heart valve procedures. Over the forecast period, all of the procedures included in this report are projected to experience growth, some faster than others, following COVID-19 headwinds.
more...